The interaction between the oropharyngeal geometry and aerosols via pressurised metered dose inhalers
- PMID: 19902336
- DOI: 10.1007/s11095-009-9994-z
The interaction between the oropharyngeal geometry and aerosols via pressurised metered dose inhalers
Abstract
Purpose: This study investigated the effect of oropharyngeal geometry on inhaled aerosol characteristics via pressurised metered dose inhalers (pMDIs), both with or without spacers.
Methods: Seven adult oropharyngeal models with different centreline lengths, total volumes, and degrees of constriction were employed as induction ports for a laser diffraction particle size analyser and cascade impactor. Particle size change over time, mass median aerodynamic diameter (MMAD), average median volume diameter (D(V)50), inhaled doses, and oropharyngeal depositions (percentage of the nominal dose) for aerosols via suspension and ultrafine pMDIs with or without spacers at 30 l/min airflow were determined.
Results: Variations in oropharyngeal geometry caused significant variations in inhaled particle size distributions, doses, oropharyngeal drug depositions, and particle size change over time when pMDIs were used without spacers. However, inhaled aerosol characteristics had marginal variations for the ultrafine pMDI plus large volume spacer (MMAD range: 0.69-0.78 microm, D(V)50 range: 1.27-1.36 microm, inhaled dose range: 46.46-52.92%). It was found that the amounts of inhaled aerosol particles with aerodynamic size of less than 0.83 microm via pMDIs plus large volume spacer were slightly affected by the oropharyngeal geometry.
Conclusion: Inhaling ultrafine aerosols via spacers may reduce the effect of oropharyngeal geometry on inhaled aerosol properties.
Similar articles
-
Effect of oropharyngeal length in drug lung delivery via suspension pressurized metered dose inhalers.Pharm Res. 2006 Jun;23(6):1364-72. doi: 10.1007/s11095-006-0163-3. Epub 2006 May 26. Pharm Res. 2006. PMID: 16715362
-
Optimizing the primary particle size distributions of pressurized metered dose inhalers by using inkjet spray drying for targeting desired regions of the lungs.Drug Dev Ind Pharm. 2015 Feb;41(2):279-91. doi: 10.3109/03639045.2013.858741. Epub 2013 Nov 19. Drug Dev Ind Pharm. 2015. PMID: 24252108
-
Assessment of Emergency Spacers Versus Traditional Spacers, An In-Vitro Model for Aerosol Delivery.AAPS PharmSciTech. 2025 May 16;26(5):138. doi: 10.1208/s12249-025-03136-1. AAPS PharmSciTech. 2025. PMID: 40379925
-
Targeting drugs to the airways: The role of spacer devices.Expert Opin Drug Deliv. 2009 Jan;6(1):91-102. doi: 10.1517/17425240802637862. Expert Opin Drug Deliv. 2009. PMID: 19236210 Review.
-
Use of spacers for patients treated with pressurized metered dose inhalers: focus on the VENTOLIN™ Mini Spacer.Expert Opin Drug Deliv. 2018 Apr;15(4):419-430. doi: 10.1080/17425247.2018.1437414. Epub 2018 Feb 12. Expert Opin Drug Deliv. 2018. PMID: 29415579 Review.
Cited by
-
Effect of Inhalation Flow Rate on Mass-Based Plume Geometry of Commercially Available Suspension pMDIs.AAPS J. 2018 Jul 12;20(5):84. doi: 10.1208/s12248-018-0241-6. AAPS J. 2018. PMID: 30003443
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources